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Abstract 
Autism is a complex behavioral disorder that develops 
prior to age three years and is distinguished by high 
heritability. Many genes predisposing to autism spectrum 
disorders (ASDs) have been identified. These findings 
have demonstrated that ASDs are etiologically 
heterogeneous; although, the mutations underlying ASDs 
are identifiable only in a minority of patients. Indeed, the 
causes of ASDs are unknown in more than 70% of patients. 
Recently, we have described two unrelated families whose 
affected individuals display a characteristic triad of 
symptoms of autism; such as impairments in social 
interaction, impairments in communication, restricted 
interests and repetitive behavior. They also displayed other 
symptoms commonly observed in autistic individuals; such 
as gait imbalance, clumsiness, mental retardation and 
epilepsy. The genetic analysis of these families resulted in 
the identification of new heterozygous point mutations in 
the KCNJ10 gene that encodes the inwardly-rectifying K+ 
channel Kir4.1 expressed predominantly, but not 
exclusively, in astrocytes. Functionally, the mutated 
channels exhibited a phenotype consistent with gain-of-
function defects. These new findings highlight the 
emerging role of inwardly-rectifying K+ channels and 
astrocyte dysfunction in autism spectrum disorders 
associated with epilepsy. 
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Introduction 
Autism spectrum disorders (ASDs) are amongst the 
most common neuropsychiatric diseases worldwide and 
their prevalence shows no discrimination in terms of 
ethnicity, family income or educational levels. The 
prevalence rates had been estimated at 1% - 2.6% of the 
world population; however. a carefully executed study 
published recently1 presented evidence for surprisingly 
high rates of these disorders (3.74% in males and 1.47% in 
females) . ASDs are highly heritable and the prevalence in 
males appears to be three to four times that of females. 
Since the description of this disease by Leo Kanner and 
Hans Asperger almost 70 years ago, it is now well 
established that ASDs represent a heterogenous group of 
disorders in terms of etiology, biology and phenotype. 
Generally, such complex disorders develop prior to age 
three years and are characterized by impairments in social 
interaction and communication, together with repetitive 
and stereotypic behaviors. Tantrums are the emotional 
outbursts most often associated with autistic children.  
 
Generally, the onset of autism is gradual; however, 
approximately 30% have a "regressive" onset. Fifty to 
seventy percent of children with autism show intellectual 
disability on nonverbal IQ testing. About 25% of children 
(who fit the diagnostic criteria for ASDs at age two or 
three years) later in life begin to talk and communicate, 
and by the age of 6-7 years blend, to varying degrees, into 
the regular school population. The remaining 75% 
continue to experience lifelong disability requiring 
intensive parental, school, and societal support. For each 
autistic individual, a cost of $3.66 million is estimated 
over a lifetime, taking into account medical care, extra 
education and lack of economic productivity. The causes 
of autism can be divided into "idiopathic," which 
comprises the majority of cases (>70%), and "secondary," 
in which an environmental agent, chromosome 
abnormality, or single-gene disorder can be identified. 
Recent studies suggest that several hundreds of loci are 
likely to contribute to the complex genetic heterogeneity of 
this group of disorders. A number of prenatal or postnatal 
conditions, chromosomal abnormalities (deletions of 
chromosomes, copy-number variations) and single gene 
disorders (e.g., Fragile X Syndrome and Tuberous 
Sclerosis) have been linked to ASD. However, with the 
exception of Rett’s Syndrome which is primarily due to 
mutations in the methyl-CpG-binding protein 2 (MECP2) 
gene, the etiology and neurobiological mechanisms 
underlying ASDs remain largely unclear. Several other 
lines of evidence indicate that genetic components are 
involved in susceptibility to ASDs, such as the much 
higher concordance rates of ASD in monozygotic twins 
(92%) than dizygotic twins (10%). Moreover, parents and 
siblings of affected children often show much milder, 
subclinical manifestations of autism, the "broad autism 
phenotype", further suggesting that ASDs can be, at 
least partially, linked to common genetic susceptibility 
factors. The high degree of clinical overlap between 
autism and epilepsy has led to the identification of a 
subgroup within the autistic spectrum, which has been 
labeled "autism-epilepsy phenotype". The risk of 
seizures in autism is reported to range between 5% and 
46%, clearly exceeding that of the general population 
(0.5-1%). On the other hand, the prevalence of autism 
in epileptic population is reported at 32%, about 50 
times higher than in the general population. Although 
the pathophysiological significance of this relationship 
is yet unsettled, it offers clues as to possible common 
genetic and molecular mechanisms responsible for 
both the seizures and the socio-cognitive and 
communicative dysfunction that define ASDs. Both an 
imbalance between the excitatory glutamatergic and 
inhibitory GABAergic systems, and variants in genes 
encoding for GABA receptor subunits, have been 
associated with autism susceptibility and seizures. A 
susceptibility locus for autism has also been mapped 
near a cluster of voltage-gated sodium channel genes 
(SCN1A and SCN2A), on chromosome 2, that are 
susceptibility genes for epilepsy (9). The identification 
of genes that appear etiologically relevant to both ASD 
and seizures could provide new insights for 
understanding the ASD-epilepsy relationship. 
 
Identification of new mutations in the Kir4.1 
channels of children displaying autism, seizures 
and intellectual disability.  
Inwardly-rectifying (Kir) potassium channels are 
expressed in a wide variety of excitable and non-
excitable tissues throughout the body where they play 
a key role in the maintenance of the resting membrane 
potential and thereby the control of cellular excitability. 
Many Kir channels also play an important role in K+ 
homeostasis by contributing to a wide range of 
different K+ transport pathways. The Kir4.1 potassium 
channel was first cloned from the brain2 where it is 
expressed predominantly, but not exclusively, in glial 
cells including both oligodendrocytes and astrocytes. 
Approximately 15 distinct Kir clones have been 
identified, forming seven major subfamilies: Kir1.0-
Kir7.0. Our research group has established important 
biophysical properties and physiological roles for 
several Kir subfamilies members.3,4 In particular, 
Kir5.1 does not produce functional K+ channel activity 
when expressed by itself. Instead it selectively co-
assembles with Kir4.1 and Kir4.2 forming heteromeric 
channels.2,5,6,7,8 Heteromultimerisation between Kir4.1 
and Kir5.1 produces an increase in single-channel 
conductance, an increase in rectification and very slow 
time-dependent activation at hyperpolarising potentials 
compared to homomeric Kir4.15. Another key property 
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of heteromeric Kir4.1/Kir5.1 channels is their inhibition by 
hypercapnic acidosis. Recently, D’Adamo and co-workers 
showed that Kir5.1 subunits confer CO2 sensitivity to 
locus coeruleus (LC) neurons.4 
 
These studies also demonstrate that the ability of Kir 
subunits to heteromultimerise adds increased functional 
diversity to a limited number of gene products. Kir4.1 
channels are encoded by the KCNJ10 gene on 
chromosome 1q22. Two early studies indicated a linkage 
between missense variations in KCNJ10 and seizure 
susceptibility in mice and in humans with temporal lobe 
and idiopathic generalized epilepsy.9,10 However, these 
studies have not been supported by solid functional 
evidence. Recordings from surgical specimens of patients 
with intractable epilepsies have demonstrated a significant 
reduction of Kir conductance in astrocytes and an impaired 
ability for potassium clearance. Furthermore, conditional 
Kir4.1 knockout mice display premature lethality and 
stress-induced seizures11. Mutations in KCNJ10 have been 
detected also in patients affected by seizures, ataxia, 
sensorineural deafness and tubulopathy (EAST 
syndrome12; SeSAME syndrome13). In vitro 
electrophysiological assays of some of the mutations 
detected in individuals with EAST\SeSAME syndrome, 
have demonstrated a large reduction of currents from 
mutant channels.14 Overall, it appears that either the 
reduction or the absence of Kir4.1 causes epilepsy. The 
relationship between Kir channels and autism spectrum 
disorders is less straightforward. A linkage study on a 
Finnish extended pedigree has proposed KCNJ10 as a 
candidate gene for ASD.15 Furthermore, an up-regulation 
of Kir4.1 has been found in LC neurons of MECP2-null 
mice, an animal model of Rett syndrome.16 This over-
expression of Kir4.1 has been hypothesized to impair the 
neuromodulation actions of the LC, leading to the 
autonomic dysfunction and autistic behaviours seen in 
patients with Rett Syndrome. 
 
Recently we have reported a mutational screening of 
KCNJ10 in 52 children with cryptogenic epilepsy, 14 of 
these also had a concurrent diagnosis of ASD.17 We 
identified two heterozygous KCNJ10 mutations p.R18Q in 
two identical twins and p.V84M in a 14-year-old child. 
Clinically, the two 8-year-old identical twins showed 
impaired social interaction, sleep difficulties, and 
hypotonia at 5 months. Two months later both exhibited 
epileptic spasms within the same 24 hour period. Other 
symptoms included clumsiness, absence of speech, severe 
disorder of social interaction, stereotypies, repetitive 
behaviors, symptoms of anxiety, depression, obsessive-
compulsive disorder and intellectual disability (IQ: 58). 
The 14-year-old child showed normal psychomotor 
development until 12 months of age, when sleep disorder, 
poor social gaze, no response to name, absence of 
language development, and withdrawal behaviors 
became evident. At 6 years, he experienced complex 
partial seizures. 
 
The p.R18Q and p.V84M mutations that we have 
identified replaced amino acid residues that are highly 
conserved throughout evolution and were undetected 
in about 500 healthy chromosomes. Reduced 
penetrance was observed in three apparently 
asymptomatic mutation carriers and in one that was 
mildly affected. Incomplete penetrance is relatively 
common in “channelopathies”, particularly when they 
affect the central nervous system. The effects of 
mutations on channel activity were functionally 
assayed using a heterologous expression system. These 
studies have indicated that the molecular mechanism 
contributing to the disease relates to an increase in 
either surface-expression or conductance of the Kir4.1 
channel.17 Unlike previous syndromic associations of 
genetic variants in KCNJ10, the pure neuropsychiatric 
phenotype in our patients suggests that the new 
mutations affect K+ homeostasis for the most part in 
the brain, acting through gain-of-function defects. 
These results provide novel insight into the etiology of 
autism/epilepsy phenotype, and a new direction for 
more effective therapeutic approaches. 
 
Postulated contributions of Kir4.1 dysfunction to 
ASD and epilepsy 
Kir4.1 channels are expressed predominantly in 
astrocytes but also in neurons. Astrocytes make up 
90% of all human brain cells and each astrocyte 
controls the activity of many thousands of synapses 
(about 140 000 in the hippocampus). Astrocytic 
Kir4.1 channels help maintain the ionic and osmotic 
environment in the extracellular space, by 
promoting K+ transport from regions of high [K+]o, 
which results from synaptic excitation, to those of 
low [K+]o. This polarized transport of K+ in 
astrocytes is essential for normal neuronal activity 
and excitability and for synaptic functions. 
Defective astrocyte-mediated regulation of [K+]o in 
the brain presents an entirely original mechanistic 
hypothesis for association between the allelic 
variations we have identified in KCNJ10 and ASD 
with seizure susceptibility and intellectual disability. 
Co-occurrence of epilepsy and ASD in patients 
harboring the KCNJ10 gain-of-function mutations 
suggests that dysfunction in the astrocytic-
dependent K+ buffering may be a common 
mechanism contributing to seizures as well as the 
core behavioral features of ASD. 
 
Although controversial, it has been proposed that 
the loss-of-function of glial potassium conductance 
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would favor extracellular K+ accumulation, contributing to 
neuronal hyper-excitability and epilepsy. Kuffler and co-
workers first demonstrated that depolarizations of glial 
cells, induced by nerve stimulations, were attributable to 
the high K+ permeability of these cells.18 Glial membrane 
potential tightly follows [K+]o variations along the 
equilibrium potential calculated with the Nernst equation. 
The role of Kir4.1 in this process has been demonstrated 
by targeted ablation of the Kir4.1 gene (Kcnj10) in mice. 
In Kir4.1 knock out glial cells no membrane potential 
variations were observed during [K+]o increases induced 
by nerve stimulations.19 These studies demonstrated the 
central role played by Kir4.1 channels in astrocyte-
operated K+ buffering. Noteworthy, homozygous Kir4.1 
knockout mice die within 2–3 weeks of birth showing 
severe motor impairment caused by dysmyelination and 
axonal degeneration.19 
 
Recently, it has been shown that isolated episodes of 
local neuronal hyperactivity trigger a large and 
synchronous calcium elevation in closely associated 
astrocytes. These activated astrocytes signal back to 
neurons, favoring the recruitment of neurons into a 
coherent activity that underlines the hypersynchronous 
ictal discharge.20 The functional analyses carried out here 
suggest, as an alternative pathogenic mechanism, that an 
increased and faster influx of K+ into astrocytes through 
Kir4.1-containing channels during intense neuronal 
activity may lead to larger membrane depolarization and 
higher intracellular calcium elevations in these cells. 
Calcium elevations in astrocytes are associated with the 
release of gliotransmitters, such as glutamate and D-serine 
that trigger discharges in neurons, promoting local 
neuronal synchrony and epileptic activity. We are tempted 
to speculate that a recurrent neuron-astrocyte-neuron 
excitatory loop may develop at a restricted brain site, as a 
consequence of gain-of-function of Kir4.1 channels, and 
contribute to the initiation of seizures. The new mutations 
that we have identified in KCNJ10 also produce gain-of-
function of the heteromeric channels formed by Kir4.1 and 
Kir5.1 subunits.17 
 
This channel type is highly expressed in astrocytes but 
also in LC neurons4. This suggests that such mutations 
may additionally alter the noradrenergic system of the 
brain. LC produces and transports all of the noradrenaline 
(NE) in the cerebral cortex and hippocampus and most of 
the NE in other parts of the neuraxis, including the 
cerebellum. Interestingly, astrocytes are the main cellular 
target of NE terminals in the brain which also form 
neuronal-glia-vascular associations.21 Therefore, NE is 
considered one of the main players in the neuronal control 
of glial activation22. Aoki and Pickel demonstrated that 
astrocytic 2 receptors are present near adrenergic nerve 
terminals, which rise form neurons originating in the LC.23 
A developmental dysregulation of this LC-NE network 
has been implicated in the modulation of autistic 
behaviors in humans. In addition, the up-regulation of 
Kir4.1 channels, which has been found in LC neurons 
of MECP2-null mice, further supports a possible 
causative role of LC dysfunction in ASD.  
 
40% to 60% of autistic children show some degree 
of mental retardation. Such defects appear closely tied 
to developmental events occurring later in childhood 
which depend on synaptic activity and activity-
dependent changes that ultimately result in synaptic 
plasticity, learning and memory formation. LC plays 
crucial roles in learning and memory processes and 
Kir4.1 has been implicated in the modulation of 
synaptic strength.11 Kir4.1 channel activity also shows 
a profound developmental regulation, which correlates 
with both cell differentiation and the developmental 
regulation of extracellular K+ dynamics, in vivo. 
Moreover, astrocyte-released neuroactive substances 
have been shown to affect neuronal excitability, 
excitatory and inhibitory synaptic transmission and 
plasticity, as well as synaptogenesis and neuronal 
wiring. Thus, either the possible effects of R18Q 
mutation in promoting channel trafficking or the 
increased single channel conductance of V84M may 
alter a number of different mechanisms related to K+ 
homeostasis, cell differentiation and synaptic plasticity 
and contribute to ASD and epilepsy insurgence.  
However, additional studies are necessary in order to 
understand how dysfunction of the KJCN10-encoded 
potassium channel causes a complex neuropsychiatric 
disease such as ASD with seizures and intellectual 
disability. Our research groups, which are at the 
firefront in fighting these disorders, will try to 
elucidate these mechanisms in the near future. 
 
Concluding remarks 
Solving the puzzle of autism is certainly an 
extremely difficult task. We have added a few pieces 
to this puzzle by identifying novel genetic defects in 
children affected by autism/epilepsy with intellectual 
disability. Despite the abundance of astrocytes in the 
CNS, to a certain extent they have been overlooked in 
the search for mechanisms underlying psychiatric 
disorders and epilepsy. Our evidence supports the 
hypothesis that astrocytes, as well as neurons, may 
play a role in at least some neuropsychiatric 
phenotypes. As a consequence, astrocytes may 
represent a crucial target for novel pharmacological 
control of abnormal electrical discharges and synaptic 
function in the CNS of children affected by such 
devastating disorders. Indeed, several tricyclic 
antidepressants, such as nortriptyline, have already 
been demonstrated to preferentially block the glial 
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Kir4.1 channel, suggesting that Kir4.1 also could be an 
important target offering new opportunities for ASD and 
epilepsy therapy. Without doubt, these studies are 
important in identifying signaling pathways and circuits 
involved in ASDs and in finding novel pharmacological 
interventions to ameliorate the symptoms. More broadly 
however, understanding these experiments of Nature helps 
us to understand the physiological workings of the human 
body.  
 
Acknowledgements 
We would like to thank Ms Samantha Austen who 
helped the authors with the preparation of this manuscript. 
The support of Telethon Italy (GGP11188) and 
COMPAGNIA di San Paolo (Turin) “Programma 
Neuroscienze”is gratefully acknowledged.  
 
References 
1. Kim YS, Leventhal BL, Koh YJ, Fombonne E, Laska E, Lim EC, 
Cheon KA, Kim SJ, Kim YK, Lee H, Song DH, Grinker RR. 
Prevalence of autism spectrum disorders in a total population 
sample. The American Journal of Psychiatry. 2011;168(9):904-12. 
2. Bond CT, Pessia M, Xia XM, Lagrutta A, Kavanaugh MP, 
Adelman JP. Cloning and expression of a family of inward rectifier 
potassium channels. Receptors and Channels. 1994;2:183-191. 
3. Pessia M, Bond CT, Kavanaugh MP, Adelman JP. Contributions 
of the C-terminal domain to gating properties of inward rectifier 
potassium channels. Neuron. 1995;14:1039-1045. 
4. D’Adamo MC, Shang L, Imbrici P, Brown SDM, Pessia M, 
Tucker S. Genetic inactivation of Kcnj16 identifies Kir5.1 as an 
important determinant of neuronal PCO2/pH sensitivity. The 
Journal of Biological Chemistry. 2011;286:192-198. 
5. Pessia M, Tucker SJ, Lee K, Bond CT, Adelman JP. Subunit 
positional effects revealed by novel heteromeric inwardly 
rectifying K+ channels. EMBO Journal. 1996;15:2980-2987. 
6. Salvatore L, D’Adamo MC, Salmona M, Polishchuk R, Pessia M 
Localization and age dependent expression of the inward rectifier 
K+ channel Kir 5.1 in a mammalian reproductive system. FEBS 
letters. 1999;449:146-152. 
7. Tucker JS, Imbrici P, Salvatore L, D’Adamo MC, Pessia M. pH-
dependence of the inwardly rectifying potassium channel Kir5.1 
and localisation in renal tubular epithelia. The Journal of 
Biological Chemistry. 2000;275:16404-16407. 
8. Pessia M, Imbrici P, D'Adamo MC, Salvatore L, Tucker SJ. 
Differential pH-sensitivity of Kir4.1 and Kir4.2 and modulation by 
heteropolymerisation with Kir5.1. Journal of Physiology (London). 
2001;532.2:359-367. 
9. Buono RJ, Lohoff FW, Sander T, et al. Association between 
variation in the human KCNJ10 potassium ion channel gene and 
seizure susceptibility. Epilepsy Research. 2004;58:175-183. 
10. Ferraro TN, Golden GT, Smith GG, et al. Fine mapping of a 
seizure susceptibility locus on mouse chromosome 1: nomination 
of Kcnj10 as a causative gene. Mammalian Genome 2004;15:239-
251. 
11. Djukic B, Casper KB, Philpot BD, Chin LS, McCarthy KD. 
Conditional knock-out of Kir4.1 leads to glial membrane 
depolarization, inhibition of potassium and glutamate uptake, 
and enhanced short term synaptic potentiation. Journal of 
Neuroscience. 2007;27:11354–11365. 
12. Bockenhauer D, Feather S, Stanescu HC, et al. Epilepsy, 
ataxia, sensorineural deafness, tubulopathy, and KCNJ10 
mutations. The New England Journal of Medicine. 
2009;360:1960-1970. 
13. Scholl UI, Choi M, Liu T, et al. Seizures, sensorineural 
deafness, ataxia, mental retardation, and electrolyte imbalance 
(SeSAME syndrome) caused by mutations in KCNJ10. 
Proceedings of the National Academy of Sciences U S A. 
2009;106:5842-5847. 
14. Reichold M, Zdebik AA, Lieberer E, et al. KCNJ10 gene 
mutations causing EAST syndrome (epilepsy, ataxia, 
sensorineural deafness, and tubulopathy) disrupt channel 
function. Proceedings of the National Academy of Sciences U 
S A. 2010;107:14490-14495. 
15. Kilpinen H, Ylisaukko-oja T, Rehnström K, et al. Linkage 
and linkage disequilibrium scan for autism loci in an extended 
pedigree from Finland. Human Molecular Genetics 
2009;18:2912-2921. 
16. Zhang X, Cui N, Wu Z, et al. Intrinsic membrane properties 
of locus coeruleus neurons in Mecp2-null mice. American 
Journal of Physiology - Cell Physiology 2010;298:C635-
C646. 
17. Sicca F, Imbrici P, D’Adamo MC, Moro F, Bonatti F, 
Brovedani P, Grottesi A, Guerrini R, Masi G, Santorelli FM, 
Pessia M. Autism with seizures and intellectual disability: 
possible causative role of Gain-of-Function of the inwardly-
rectifying K+ channel Kir4.1. Neurobiology of Disease. 
2011;43:239-247. 
18. Orkand RK, Nicholls JG, Kuffler SW. Effect of nerve 
impulses on the membrane potential of glial cells in the 
central nervous system of amphibia. Journal of 
Neurophysiology 1966;29:788-806. 
19. Chever O, Djukic B, McCarthy KD, Amzica F. Implication of 
k(ir)4.1 channel in excess potassium clearance: an in vivo 
study on anesthetized glial-conditional Kir4.1 knock-out 
mice. Journal of Neuroscience 2010;30:15769-15777. 
20. Gómez-Gonzalo M, Losi G, Chiavegato A, Zonta M, 
Cammarota M, Brondi M, Vetri F, Uva L, Pozzan T, de Curtis 
M, Ratto GM, Carmignoto G. An excitatory loop with 
astrocytes contributes to drive neurons to seizure threshold. 
PLoS Biology. 2010;8:e1000352. 
21. Cohen Z, Molinatti G, Hamel E. Astroglial and vascular 
interactions of noradrenaline terminals in the rat cerebral 
cortex. Journal of Cerebral Blood Flow & Metabolism. 1997; 
894-904. 
22. Carnevale D, De Simone R, Minghetti L. Microglia-neuron 
interaction in inflammatory and degenerative diseases: role of 
cholinergic and noradrenergic systems. CNS & Neurological 
Disorders - Drug Targets. 2007;6:388-97. 
23. Aoki C, Pickel VM. Ultrastructural relations between beta-
adrenergic receptors and catecholaminergic neurons. Brain 
Research Bulletin. 1992;3-4:257-63. 
    
 
 
